Antiretroviral exposure. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

CD4-Positive T-Lymphocytes Plasma CD8-Positive T-Lymphocytes

Organisms2

Diseases21

HIV Infections Acquired Immunodeficiency Syndrome AIDS-Related Opportunistic Infections HIV-Associated Lipodystrophy Syndrome HIV Seropositivity Pregnancy Complications, Infectious Viremia Immune Reconstitution Inflammatory Syndrome AIDS Dementia Complex Coinfection Lymphoma, AIDS-Related Lipodystrophy HIV Wasting Syndrome Cytomegalovirus Retinitis Tuberculosis Disease Progression AIDS-Associated Nephropathy Acidosis, Lactic Substance Abuse, Intravenous Sarcoma, Kaposi Hepatitis C

Chemicals and Drugs34

Anti-HIV Agents Anti-Retroviral Agents Reverse Transcriptase Inhibitors HIV Protease Inhibitors Zidovudine Nevirapine Benzoxazines Stavudine RNA, Viral Ritonavir Organophosphonates Lopinavir Lamivudine Adenine Indinavir Pyrimidinones Nelfinavir Didanosine HIV Reverse Transcriptase Dideoxynucleosides HIV Protease Oxazines Saquinavir Antitubercular Agents pol Gene Products, Human Immunodeficiency Virus Antiviral Agents Pyrrolidinones HIV Fusion Inhibitors HIV Integrase Inhibitors Protease Inhibitors Cyclohexanes DNA, Viral Integrase Inhibitors Drugs, Generic

Analytical, Diagnostic and Therapeutic Techniques and Equipment26

Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Viral Load Drug Therapy, Combination Cohort Studies Treatment Failure Treatment Outcome Lost to Follow-Up Drug Monitoring Drug Administration Schedule Directly Observed Therapy Prospective Studies Retrospective Studies Risk Factors Cross-Sectional Studies Follow-Up Studies Prevalence Longitudinal Studies Withholding Treatment CD4-CD8 Ratio Incidence Chemoprevention Multivariate Analysis Lymphocyte Count Proportional Hazards Models Logistic Models

Psychiatry and Psychology5

Medication Adherence Patient Compliance AIDS Dementia Complex Treatment Refusal Substance Abuse, Intravenous

Phenomena and Processes16

CD4 Lymphocyte Count Viral Load Drug Resistance, Viral Drug Resistance, Multiple, Viral Time Factors Virus Replication Pregnancy Genotype CD4-CD8 Ratio Drug Interactions Mutation HIV Seronegativity Lymphocyte Count Genes, pol Viral Tropism Virus Latency

Anthropology, Education, Sociology and Social Phenomena2

Developing Countries Treatment Refusal

Information Science2

Prevalence Incidence

Named Groups2

HIV Long-Term Survivors Infant, Newborn

Health Care22

Medication Adherence Infectious Disease Transmission, Vertical Patient Compliance Cohort Studies Treatment Failure Treatment Outcome Prospective Studies Retrospective Studies Risk Factors Cross-Sectional Studies Follow-Up Studies Prevalence Longitudinal Studies Withholding Treatment Treatment Refusal Incidence Health Services Accessibility Multivariate Analysis Proportional Hazards Models Logistic Models Health Resources Rural Population

Geographicals22

South Africa Uganda Botswana Malawi Cote d'Ivoire Africa South of the Sahara Zambia Africa, Southern Zimbabwe Lesotho Thailand Cameroon Kenya Rwanda Haiti British Columbia Tanzania Cambodia Brazil Africa United States India

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Anti-HIV Agents HIV Infections Antiretroviral Therapy, Highly Active Anti-Retroviral Agents CD4 Lymphocyte Count Viral Load HIV-1 Drug Resistance, Viral Reverse Transcriptase Inhibitors HIV HIV Protease Inhibitors Acquired Immunodeficiency Syndrome Zidovudine Nevirapine Medication Adherence South Africa Infectious Disease Transmission, Vertical Benzoxazines AIDS-Related Opportunistic Infections Stavudine RNA, Viral Ritonavir Drug Therapy, Combination Organophosphonates Patient Compliance Lopinavir HIV-Associated Lipodystrophy Syndrome Cohort Studies Lamivudine HIV Seropositivity Pregnancy Complications, Infectious Drug Resistance, Multiple, Viral Uganda Adenine Treatment Failure Treatment Outcome Indinavir Viremia Immune Reconstitution Inflammatory Syndrome CD4-Positive T-Lymphocytes Botswana Lost to Follow-Up Pyrimidinones Nelfinavir Didanosine AIDS Dementia Complex HIV Reverse Transcriptase Malawi Dideoxynucleosides Drug Monitoring Coinfection Drug Administration Schedule Cote d'Ivoire Africa South of the Sahara Directly Observed Therapy HIV Protease Prospective Studies Zambia Lymphoma, AIDS-Related Lipodystrophy Oxazines Retrospective Studies Time Factors Risk Factors Saquinavir Africa, Southern Cross-Sectional Studies Developing Countries Virus Replication Zimbabwe HIV Wasting Syndrome Cytomegalovirus Retinitis Pregnancy Tuberculosis Follow-Up Studies Prevalence Antitubercular Agents Plasma Disease Progression Lesotho pol Gene Products, Human Immunodeficiency Virus Antiviral Agents Genotype Longitudinal Studies Withholding Treatment Pyrrolidinones HIV Fusion Inhibitors Treatment Refusal CD4-CD8 Ratio Incidence Drug Interactions HIV Integrase Inhibitors Thailand HIV Long-Term Survivors Cameroon Kenya AIDS-Associated Nephropathy CD8-Positive T-Lymphocytes Rwanda Haiti

No FAQ available that match "antiretroviral exposure"